MNA
BIIB icon

Manning & Napier Advisors’s Biogen BIIB Stock Holding History

Manning & Napier Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$231M Sell
737,735
-76,634
-9% -$22.7M 1.98% 11
2017
Q2 		$221M Buy
814,369
+691,694
+564% +$183M 1.9% 14
2017
Q1 		$33.5M Buy
+122,675
New +$34.7M 0.26% 60

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Manning & Napier Advisors's BIIB Position: Q3 2017 in Review

Manning & Napier Advisors reduced its Biogen (BIIB) stake by 9.4% in Q3 2017, selling an estimated $22.7M and leaving 737,735 shares worth $231M. The position accounts for 1.98% of the portfolio, ranked #11.

Manning & Napier Advisors first reported a position in BIIB in Q1 2017 and has held it in 3 quarters since. 1,015 funds tracked by Wall St. Rank hold BIIB as of Q3 2017.

  • Manning & Napier Advisors held 737,735 shares of Biogen worth $231M as of Q3 2017.
  • Manning & Napier Advisors sold 76,634 Biogen shares in Q3 2017, an estimated $22.7M.
  • Biogen made up 1.98% of Manning & Napier Advisors's portfolio in Q3 2017, its #11 holding.
  • Manning & Napier Advisors first reported a position in Biogen in Q1 2017 and has held it in 3 quarters since.
  • 1,015 funds tracked by Wall St. Rank held Biogen as of Q3 2017.

Based on Manning & Napier Advisors's 13F filing for Q3 2017, filed 7 Nov 2017.